Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

NCT00483353 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer